potassium gluconate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
4524 299-27-4

Description:

MoleculeDescription

Synonyms:

  • potassium gluconate
  • gluconic acid monopotassium salt
  • gluconic acid potassium salt
  • Molecular weight: 234.25
  • Formula: C6H11KO7
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 141.28
  • ALOGS:
  • ROTB: None

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Blood creatine increased 134.39 22.31 31 1686 5570 63481735
Dehydration 57.42 22.31 43 1674 173311 63313994
Diarrhoea 24.36 22.31 57 1660 715309 62771996
Pyroglutamic acidosis 23.39 22.31 5 1712 630 63486675
Blood potassium decreased 22.34 22.31 14 1703 42012 63445293

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Toxic epidermal necrolysis 153.58 26.47 45 869 21601 34934416

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Blood creatine increased 114.95 20.64 31 2365 9424 79732568
Toxic epidermal necrolysis 114.89 20.64 45 2351 44536 79697456
Dehydration 51.07 20.64 49 2347 248138 79493854
Pneumonia 25.47 20.64 59 2337 660187 79081805

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC A12BA05 ALIMENTARY TRACT AND METABOLISM
MINERAL SUPPLEMENTS
POTASSIUM
Potassium

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Hypokalemia indication 43339004
Hypokalemia Prevention indication
Hyperkalemia contraindication 14140009
Complete atrioventricular block contraindication 27885002
Gastrointestinal ulcer contraindication 40845000
Congenital myotonia, autosomal dominant form contraindication 57938005
Acute nephropathy contraindication 58574008
Gastrointestinal obstruction contraindication 126765001
Gastroparesis contraindication 235675006
Chronic diarrhea contraindication 236071009
Hyporeninemic hypoaldosteronism contraindication 236464008
Familial hyperkalemic periodic paralysis contraindication 304737009 DOID:14451
Severe dehydration contraindication 450316000




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D01298 KEGG_DRUG
4018112 VUID
N0000146450 NUI
4018112 VANDF
CHEBI:32032 CHEBI
CHEMBL2106978 ChEMBL_ID
DB13620 DRUGBANK_ID
12H3K5QKN9 UNII
89903 RXNORM
5331 MMSL
6390 MMSL
d03789 MMSL
000768 NDDF
424654004 SNOMEDCT_US
89219006 SNOMEDCT_US
C0301527 UMLSCUI
16760467 PUBCHEM_CID

Pharmaceutical products:

None